A Double Blind, Randomized, Placebo-controlled, Multi-center, Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients Diagnosed With Mild and Moderate COVID-19
et al., NCT04891302, NCT04891302, Jul 2021
104 patient clevudine late treatment RCT with results not reported over 4 years after completion.
Song et al., 8 Jul 2021, Double Blind Randomized Controlled Trial, placebo-controlled, South Korea, trial NCT04891302 (history).
Late treatment
is less effective
is less effective
